Sequential hemi-body radiotherapy in advanced multiple myeloma.
Eleven patients with advanced multiple myeloma refractory to standard chemotherapy were treated with a regimen of sequential hemi-body radiotherapy consisting of 800 rad midplane in a single dose to each half. 9/10 patients experienced significant relief of skeletal pain and there were 5/11 objective tumor responses with one complete remission. Treatment-related morbidity was significant and consisted primarily of nausea and emesis, bone marrow suppression, and pneumonitis. This therapy is helpful in the management of advanced myeloma, and should be studied earlier in the course of the disease.
D001859:Bone Neoplasms / Q000532:radiotherapy; D006801:Humans; D009101:Multiple Myeloma / Q000532:radiotherapy*; D010166:Palliative Care; D011014:Pneumonia / Q000209:etiology; D011832:Radiation Injuries / Q000209:etiology; D011882:Radiotherapy, High-Energy; D012075:Remission, Spontaneous; D013280:Stomatitis / Q000209:etiology; D014839:Vomiting / Q000209:etiology